XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
41.82
+0.12 (0.29%)
Jun 4, 2026, 10:01 AM EDT - Market open

XOMA Royalty Revenue

XOMA Royalty had revenue of $12.32M in the quarter ending March 31, 2026, a decrease of -22.59%. This brings the company's revenue in the last twelve months to $48.56M, up 13.16% year-over-year. In the year 2025, XOMA Royalty had annual revenue of $52.15M with 83.06% growth.

Revenue (ttm)
$48.56M
Revenue Growth
+13.16%
P/S Ratio
10.77
Revenue / Employee
$3,468,214
Employees
14
Market Cap
524.47M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202552.15M23.66M83.06%
Dec 31, 202428.49M23.73M498.72%
Dec 31, 20234.76M-1.27M-21.06%
Dec 31, 20226.03M-32.13M-84.21%
Dec 31, 202138.16M8.78M29.86%
Dec 31, 202029.39M11.02M59.96%
Dec 31, 201918.37M13.07M246.67%
Dec 31, 20185.30M-47.39M-89.94%
Dec 31, 201752.69M47.13M846.98%
Dec 31, 20165.56M-49.88M-89.97%
Dec 31, 201555.45M36.58M193.90%
Dec 31, 201418.87M-16.59M-46.78%
Dec 31, 201335.45M1.67M4.94%
Dec 31, 201233.78M-24.41M-41.95%
Dec 31, 201158.20M24.56M72.99%
Dec 31, 201033.64M-64.79M-65.82%
Dec 31, 200998.43M30.44M44.78%
Dec 31, 200867.99M-16.27M-19.31%
Dec 31, 200784.25M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group389.42M
Valneva SE180.25M
Gyre Therapeutics117.05M
Arvinas89.40M
4D Molecular Therapeutics88.24M
ProKidney889.00K
Revenue Rankings